Title: Infusion Pumps Market Segmentation Detailed Study with Forecast to 2026
1Product Type - Insulin Pumps, PCA Pumps, Enteral
Pumps Application - Diabetes Management, Pain
Management, Chemotherapy End user - Hospitals,
Ambulatory Care Settings, Home Care Settings -
Forecast 2018 - 2026
Hemostasis Valves Market
2Table of Content
Sr. No. Content
Chapter1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary Global Trocars Market
Chapter 4 Market Overview
Chapter 5 Global Infusion Pumps Market Analysis and Forecasts, by Product
Chapter 6 Global Infusion Pumps Market Analysis and Forecasts, by Application
Chapter 7 Global Infusion Pumps Market Analysis and Forecasts, by End-user
Chapter 8 Global Infusion Pumps Market Analysis and Forecasts, by Geography/Region
Chapter 9 North America Infusion Pumps Market Analysis and Forecast
Chapter 10 Europe Infusion Pumps Market Analysis and Forecast
Chapter 11 Asia Pacific Infusion Pumps Market Analysis and Forecast
Chapter 12 Latin America Infusion Pumps Market Analysis and Forecast
Chapter 13 Middle East Africa Infusion Pumps Market Analysis and Forecast
Chapter 14 Competition Landscape
3Infusion Pumps Market Snapshot
- Infusion pumps are mainly used in hospitals and
other healthcare service providers to deliver
fluids and medication in to patients body in
controlled manner. - Global infusion pumps market is segmented into
insulin pumps, PCA pumps, and enteral pumps. - Based on the application, the global infusion
pumps market is segmented into diabetes
management, pain management, and chemotherapy. - Rise in the number of patients affected by
chronic pain and diabetes and launch of
technologically advanced products with improved
features are likely to fuel the global infusion
pumps market from 2018 to 2026.
4(No Transcript)
5Reports Highlights
- Infusion pumps market was valued at approximately
US 7,036 Mn in 2017 and is anticipated to
surpass US 10,000.0 Mn by 2026, expanding at a
CAGR of 5.4 from 2018 to 2026. - Key Player - F. Hoffmann-La Roche Ltd., ICU
MEDICAL, INC., Tandem Diabetes Care, Inc., Smiths
Medical, and Medtronic plc.
Request Sample
6(No Transcript)